secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001606498-26-000061
Event type: earnings
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical announces Q1 2026 results; filing includes no financial figures
------------------------------------------------------------------------------

- Press release issued May 5, 2026 covering three months ended March 31, 2026.
- No specific revenue, EPS, or segment data available in the filing excerpt.
- Investors should refer to the full press release for detailed results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/avns-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001606498-26-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer